The growing child with thalassaemia

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue 4, 2006, Pages 467-469

  Skordis, Nicos ^a  

^a Archbishop Makarios III Hospital   (Cyprus)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; DEFEROXAMINE; FERRITIN; GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; HEMOGLOBIN; IRON; SEX HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

AMENORRHEA; ANEMIA; BLOOD TRANSFUSION; BONE DISEASE; BONE DYSPLASIA; BONE MARROW TRANSPLANTATION; BONE MASS; BONE MINERALIZATION; CELL DEATH; CHELATION THERAPY; CHILD GROWTH; DRUG EFFICACY; FERRITIN BLOOD LEVEL; GONAD DYSFUNCTION; GRAFT VERSUS HOST REACTION; GROWTH ACCELERATION; GROWTH RATE; GROWTH RETARDATION; HEMOGLOBIN BLOOD LEVEL; HEMOSIDEROSIS; HORMONAL REGULATION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IRON CHELATION; LIFE EXPECTANCY; NOTE; PATIENT COMPLIANCE; PROVOCATION TEST; QUALITY OF LIFE; SHORT STATURE; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; FEMALE; GROWTH AND DEVELOPMENT; GROWTH DISORDERS; HUMANS; HYPOGONADISM; IRON CHELATING AGENTS; MALE; PREGNANCY; PUBERTY;

EID: 33646853552     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. Skordis N, Gourni M, Kanaris C, Toumba M, Kleanthous M, Karatzia N, Pavlides N, Angastiniotis M. The impact of iron overload and genotype on gonadal function in women with thalassaemia major. Pediatr Endocrinol Rev 2004; 2 (Suppl 2): 292-295.
2. De Sanctis V. Growth and puberty and its management in thalassaemia. Horm Res 2002; 58 (Suppl 1): 72-79.
3. Raiola G, Galati MC, De Sanctis V, Caruso-Nicoletti M, Pintor C, De Simone M, Arcuri VM, Anastasi S. Growth and puberty in thalassaemia major. J Pediatr Endocrinol Metab 2003; 16: 259-266.
4. De Sanctis V, Urso L. Clinical experience with growth hormone treatment in patients with beta-thalassaemia major. Bio Drugs 1999; 11: 79-85.
5. Filosa A, Di Maio S, Baron I, Esposito G, Galati MG. Final height and body disproportion in thalassaemic boys and girls with spontaneous or induced puberty. Acta Paediatr 2000; 89: 1295-1301.
6. De Sanctis V, Roos M, Gasser T, Fortini M, Raiola G, Galati MC; Italian Working Group on Endocrine Complications in Non-Endocrine Diseases. Impact of long-term iron chelation therapy on growth and endocrine functions in thalassaemia. J Pediatr Endocrinol Metab 2006; 19: 471-480.
7. Caruso-Nicoletti M, De Sanctis V, Raiola G, Skordis N, Manusco M, Coco M, Wonke B. No difference in pubertal growth and final height between treated hypogonadal and non-hypogonadal thalassaemic patients. Horm Res 2004; 62: 17-22.
8. Bielinski BK, Darbyshire PJ, Mathers L, Crabtree NJ, Kirk JM, Stirling HF, Shaw NJ. Impact of disordered puberty on bone density in beta-thalassaemia major. Br J Haematol 2003; 120: 353-358.
9. Vlachopapadopoulou E, Kitra V, Peristeri J, Gousetis E, Karachaliou F, Petropoulos D, Fotinou A, Michalakos S, Graphakos S. Gonadal function of young patients with beta-thalassaemia following bone marrow transplantation. J Pediatr Endocrinol Metab 2005; 18: 477-483.
10. Skordis N, Petrikkos L, Toumba M, Simamonian K, Hadjigavriel M, Sitarou M, Kolnakou A, Skordos G, Pangalou E, Christou S. Update on fertility in thalassaemia major. Pediatr Endocrinol Rev 2004; 2 (Suppl 2): 296-302.